TNOX Tanox (MM)

HOUSTON, Nov. 29 /PRNewswire/ -- Tanox, Inc. (NASDAQ:TNOX) will present at the First Albany Capital Annual Growth Conference, scheduled for Dec. 6-7, 2005 in New York City. Members of the Tanox senior management team will present at the conference Dec. 7 at 11:20 a.m., EST. The company update will review 2005 achievements, highlight TNX-355 clinical-trial results and provide an overview of 2006 corporate objectives. An audio webcast of the presentation will be accessible on the company Web site at http://www.tanox.com/ in the Investor Relations section. Presentation slides will be available on the site following the webcast. About Tanox, Inc. Tanox is a biotechnology company specializing in the discovery and development of biotherapeutics based on monoclonal antibody technology. The company develops innovative therapeutic agents for the treatment of immune-mediated diseases, inflammation, infectious disease and cancer. Tanox is based in Houston, Texas and maintains a manufacturing facility in San Diego, California. Additional corporate information is available at http://www.tanox.com/. http://www.newscom.com/cgi-bin/prnh/20050207/TNOXLOGO DATASOURCE: Tanox, Inc. CONTACT: Steve Sievert of Tanox, Inc., +1-713-578-4211, Web site: http://www.tanox.com/

Copyright